From: In vivo efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo
ASAQ
AL
p value
Patients with parasite positivity at D2
18 (13.7 %)
27 (20.0 %)
0.173
Patients with parasite positivity at D3
2 (1.5 %)
6 (4.4 %)
0.167